Indian Fluticasone Exporters: Complete Supplier Ranking with Market Share — 239 Manufacturers (2026) — TransData Nexus

Q: Who is the largest fluticasone supplier from India?

CIPLA LIMITED is the largest fluticasone exporter from India with a 91.0% market share and export value of $184.7M.

Q: How many fluticasone suppliers are there in India?

There are 239 active fluticasone exporters in India, collectively shipping $203.0M worth of fluticasone across 9,009 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top fluticasone suppliers from India?

The top 5 fluticasone suppliers from India — CIPLA LIMITED, HETERO LABS LIMITED, MEDISPRAY LABORATORIES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, SAVA HEALTHCARE LIMITED — together control 95.9% of total fluticasone export value from India.

Suresh Sormare

Fluticasone

India Pharmaceutical Trade Intelligence

$203.0M239 Suppliers123 CountriesHS 30049099

ExportsIndia → NETHERLANDS34.2%India → AUSTRALIA10.1%

ImportsUNITED KINGDOM → India$2.6B UNITED STATES → India$54.3M

#1 Supplier: CIPLA LIMITED

Fluticasone Suppliers from India (2026) — 239 Exporters, $203.0M Market | TransData Nexus | TransData Nexus

Who Exports Fluticasone from India — 239 Suppliers Behind a $203.0M Market

India's fluticasone export market is supplied by 239 active exporters who collectively shipped $203.0M across 9,009 shipments. CIPLA LIMITED leads with a 91.0% market share, followed by HETERO LABS LIMITED and MEDISPRAY LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 95.9% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Fluticasone Suppliers & Exporters — 239 manufacturers, $203.0M export market, top destinations and formulations — Fluticasone supplier data — 239 exporters · $203.0M market · 9,009 shipmentsTransData Nexus · Indian Customs Data

Top Fluticasone Exporters from India — Ranked by Export Value

CIPLA LIMITED is the leading fluticasone exporter from India, holding a 91.0% share of the $203.0M market across 9,009 shipments from 239 exporters. The top 5 suppliers — CIPLA LIMITED, HETERO LABS LIMITED, MEDISPRAY LABORATORIES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, SAVA HEALTHCARE LIMITED — collectively control 95.9% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (91.0%), HETERO LABS LIMITED (2.2%), MEDISPRAY LABORATORIES PRIVATE LIMITED (1.3%), ZYDUS LIFESCIENCES LIMITED (0.8%), SAVA HEALTHCARE LIMITED (0.5%).

Top Fluticasone Exporters from India

Ranked by export value · 239 active suppliers · Indian Customs (DGFT) data

May 2026

Top Fluticasone Exporters from India — Ranked by Export Value. 239 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	CIPLA LIMITED

Fluticasone — Export Intelligence Video

Visual overview of India's fluticasone supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's fluticasone pharmaceutical supplier landscape — $203.0M in total trade, 239 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Fluticasone exporters

Certification and compliance status for top Fluticasone suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Warning Letter (November	Yes	Yes	276	Received FDA warning letter for Pithampur facility in November 2023.
HETERO LABS LIMITED	Approved	Yes	Yes	303	Hetero Labs has received approvals from US FDA, WHO-GMP, and EU GMP.
ZYDUS LIFESCIENCES LIMITED	Approved	Yes	Yes	Unknown	Zydus Lifesciences has received approvals from US FDA, WHO-GMP, and EU GMP.
SAVA HEALTHCARE LIMITED	Approved	Yes	Yes	Unknown	Sava Healthcare has received approvals from US FDA, WHO-GMP, and EU GMP.
MIDAS CARE PHARMACEUTICALS PVT LTD	Approved	Yes	Yes	Unknown	Midas Care Pharmaceuticals has received approvals from US FDA, WHO-GMP, and EU G
MARKSANS PHARMA LIMITED	Approved	Yes	Yes	Unknown	Marksans Pharma has received approvals from US FDA, WHO-GMP, and EU GMP.
CADILA HEALTHCARE LIMITED	Approved	Yes	Yes	Unknown	Cadila Healthcare has received approvals from US FDA, WHO-GMP, and EU GMP.
PLEASANT EXPORTS	Approved	Yes	Yes	Unknown	Pleasant Exports has received approvals from US FDA, WHO-GMP, and EU GMP.

TransData Nexus reviewed the regulatory standing of 8 leading Fluticasone exporters from India. 7 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Fluticasone sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Pharma Capital of India," is a leading center for bulk drug manufacturing, accounting for approximately 40% of the country's bulk drug production. The city hosts over 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The presence of Genome Valley, a premier biotech cluster, further enhances Hyderabad's capabilities in pharmaceutical research and development.

The establishment of Hyderabad Pharma City, envisioned as the world's largest integrated pharmaceutical hub, underscores the city's commitment to advancing pharmaceutical manufacturing and innovation.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes 33% to India's drug manufacturing and 28% to drug exports, with Ahmedabad and Vadodara being pivotal hubs. Notable companies such as Zydus Lifesciences Limited and Alembic Pharmaceuticals are headquartered here, specializing in the production of finished dosage forms.

Vadodara, in particular, has a rich history in the pharmaceutical sector, being home to Alembic Pharmaceuticals, established in 1907. The city's strategic location and industrial infrastructure make it a key player in the formulations segment.

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Fluticasone exporters from India

January 15, 2026

M&A

Zydus Lifesciences Limited — Zydus acquires Agenus' U.S. biologics manufacturing facilities

Zydus Lifesciences Limited completed the acquisition of Agenus Inc.'s biologics manufacturing facilities in the United States, establishing a new subsidiary, Zylidac Bio LLC, to provide contract development and manufacturing organization (CDMO) services globally. IMPACT: This acquisition enhances Zydus' manufacturing capabilities, potentially increasing Fluticasone production capacity.

Impact: This acquisition enhances Zydus' manufacturing capabilities, potentially increasing Fluticasone production capacity.

September 2024

M&A

Zydus Lifesciences Limited — Zydus acquires 50% stake in Sterling Biotech Limited

Zydus Lifesciences Limited acquired a 50% equity stake in Sterling Biotech Limited, a company specializing in gelatin, di-calcium phosphate, and select active pharmaceutical ingredients, marking Zydus' entry into specialized biotech products for health and nutrition. IMPACT: This strategic move may diversify Zydus' product portfolio, indirectly affecting Fluticasone production.

Impact: This strategic move may diversify Zydus' product portfolio, indirectly affecting Fluticasone production.

Common Questions — Fluticasone Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which fluticasone supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, CIPLA LIMITED leads with 2,663 recorded shipments worth $184.7M. HETERO LABS LIMITED (112 shipments) and MEDISPRAY LABORATORIES PRIVATE LIMITED (19 shipments) are also established high-volume exporters.

Q How many fluticasone manufacturers are there in India?

India has 239 active fluticasone exporters with a combined export market of $203.0M across 9,009 shipments to 123 countries. The top 5 suppliers hold 95.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for fluticasone from India?

Average FOB unit price: $17.14 per unit, ranging from $0.01 to $3871.76. Average shipment value: $22.5K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fluticasone

Fluticasone

Who Exports Fluticasone from India — 239 Suppliers Behind a $203.0M Market

Top Fluticasone Exporters from India — Ranked by Export Value

Top Fluticasone Exporters from India

Related Analysis

Need Details?

Fluticasone — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Zydus Lifesciences Limited — Zydus acquires Agenus' U.S. biologics manufacturing facilities

Zydus Lifesciences Limited — Zydus acquires 50% stake in Sterling Biotech Limited

Common Questions — Fluticasone Suppliers from India

Q Which fluticasone supplier from India is the most reliable for bulk orders?

Q How many fluticasone manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for fluticasone from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Zydus Lifesciences Limited — Zydus enters medical devices market with Amplitude Surgical acquisition

Analysis Methodology